MICHAIL KOUREAS

Dr. MICHAIL KOUREAS


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2020 in Eurosurveillance
Verified
Journal Article
Open access
ZBZacharoula Bogogiannidou
Zacharoula Bogogiannidou
AVAlexandros Vontas
Alexandros Vontas
KDKaterina Dadouli
Katerina Dadouli
MKMaria Kyritsi
Maria Kyritsi
SSSoteris Soteriades
Soteris Soteriades
Christos HadjichristodoulouChristos Hadjichristodoulou
Christos Hadjichristodoulou
A serosurvey of IgG antibodies against severe acute respiratory coronavirus 2 (SARS-CoV-2) was performed during March and April 2020. Among 6,586 leftover sera, 24 (0.36%) were positive, with higher prevalence in females, older individuals and residents of large urban areas. Seroprevalence was estimated at 0.02% and 0.25%, respectively, in March and April, infection fatality rate at 2.66% and 0.54%. Our findings confirm low COVID-19 incidence in Greece and possibly the effectiveness of early measures.

KFKONSTANTINOS GEORGE FOTIADIS
KONSTANTINOS GEORGE FOTIADIS
KDKaterina Dadouli
Katerina Dadouli
IAIoanna Avakian
Ioanna Avakian
ZBZacharoula Bogogiannidou
Zacharoula Bogogiannidou
Varvara MouchtouriVarvara Mouchtouri
Varvara Mouchtouri
Christos HadjichristodoulouChristos Hadjichristodoulou
Christos Hadjichristodoulou
A Knowledge, Attitudes and Practices (KAP) study was conducted at the end of May 2021 engaging 1456 healthcare workers (HCWs) from 20 hospitals throughout Greece. Acceptance of vaccination against coronavirus disease 2019 (COVID-19) was estimated at 77.7%, with lower vaccine acceptance identified in nurses compared to physicians. Fears related to vaccine safety, lack of information and general knowledge about vaccinations, influenza vaccine acceptance, education level and years of practice were among the factors independently associated with vaccine acceptance. A strong association was identified between vaccination of HCWs in each health region and the population coverage, indicating that HCWs may be role models for the general population. Information campaigns should continue despite decisions taken regarding mandatory vaccinations.

MKMICHAIL KOUREAS
MICHAIL KOUREAS
MSMatthaios Speletas
Matthaios Speletas
ZBZacharoula Bogogiannidou
Zacharoula Bogogiannidou
DBDimitris Babalis
Dimitris Babalis
VPVassilios Pinakas
Vassilios Pinakas
Christos HadjichristodoulouChristos Hadjichristodoulou
Christos Hadjichristodoulou
A COVID-19 outbreak occurred among residents of a Roma settlement in Greece (8 April–4 June 2020). The aim of this study was to identify factors associated with an increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and to evaluate the effectiveness of control measures implemented. Data were analyzed from individuals that were tested for SARS-CoV-2 during contact tracing, population screening or hospital visits. RT-PCR was used for the detection of SARS-CoV-2 in oropharyngeal samples. Risk factors for household secondary attack rates (SAR) and hospitalization with COVID-19 were examined using chi-square tests, Fisher’s exact tests and logistic regression analyses. During the outbreak, 142 cases, 20 hospitalizations and 1 death were recorded, with a total of 2273 individuals tested. The risk of hospitalization was associated with age (OR: 1.04, 95% CI: 1.02–1.07) and Cycle threshold (Ct) values (OR for a decrease in Ct values by 1: 1.18, 95% CI: 1.07–1.31). Household SAR was estimated at 38.62% (95% CI: 32.50–45.01%). After the designation of an isolation facility for cases, household SAR declined from 74.42% to 31.03%. Household size was associated with the risk of infection (OR: 2.65, 95% CI: 1.00–7.07). The presence of COVID-19 symptoms among index cases was correlated with higher transmission (OR: 23.68, 95% CI 2.21–253.74) in multivariate analysis, while age was found to be associated with SAR only in univariate analysis. Roma communities can be particularly vulnerable to the spread of SARS-CoV-2. In similar settings, symptomatic cases are more important transmitters of SARS-CoV-2. Within these communities, immediate measures should be implemented to mitigate disease spread.

6 November 2025 in Dairy
Verified
Journal Article
Open access
PDF file
EMErmioni Meleti
Ermioni Meleti
MKMICHAIL KOUREAS
MICHAIL KOUREAS
AMAthanasios Vasileios Manouras
Athanasios Vasileios Manouras
PGPersephoni Giannouli
Persephoni Giannouli
EMEleni Malissiova
Eleni Malissiova
Bioactive peptides (BAPs) from dairy products have garnered increasing attention as natural agents with health-promoting properties, including antihypertensive, antioxidant, antimicrobial, immunomodulatory, opioid, and antidiabetic activities. This systematic review synthesizes research published between 2014 and 2024, retrieved from Scopus and PubMed, and selected according to PRISMA guidelines. A total of 192 studies met the inclusion criteria, collectively reporting over 3200 distinct peptides, with antihypertensive sequences, predominantly angiotensin-converting enzyme (ACE) inhibitors, constituting the largest category (n = 1237). β-casein was the principal precursor across bioactivities, followed by αs1-casein, β-lactoglobulin, and α-lactalbumin. Peptides were primarily produced via enzymatic hydrolysis, microbial fermentation, and gastrointestinal digestion, with peptide profiles influenced by the type of milk, microbial strains, and processing conditions. While cow’s milk remained the dominant source, investigations into goat, sheep, camel, buffalo, and donkey milk revealed species-specific biopeptides. Recent advances in proteomics have enhanced peptide identification and bioactivity prediction, enabling the discovery of novel sequences. These findings underscore the significant potential of dairy-derived BAPs as functional food components and nutraceutical ingredients, while highlighting the need for further in vivo validation, bioavailability studies, and broader exploration of underrepresented milk sources.

20 August 2024 in Dairy
Verified
Journal Article
Open access
PDF file
EMEleni Malissiova
Eleni Malissiova
GTGaryfallenia Tsinopoulou
Garyfallenia Tsinopoulou
EGEffrosyni Gerovasileiou
Effrosyni Gerovasileiou
EMErmioni Meleti
Ermioni Meleti
GSGeorgia Soultani
Georgia Soultani
AMAthanasios Vasileios Manouras
Athanasios Vasileios Manouras
Aflatoxin M1 (AFM1) is a major carcinogenic compound found in milk and dairy products, posing a constant risk to consumers in the Mediterranean region. This study systematically reviewed AFM1 presence in these products in Mediterranean countries over a period of 20 years and estimated the relevant nutritional exposure for consumers. Using data from three databases, 596 articles were retrieved with 123 meeting the inclusion criteria. The frequency of AFM1 occurrence was 40% regardless of milk type, with non-cow milk showing an increasing trend. Moreover, the Estimated Daily Intake of AFM1 from milk and dairy product consumption and the associated Hazard Index were determined. Notably, Southeastern Mediterranean countries presented higher contamination levels, leading to elevated Estimated Daily Intake and Hhazard Index values. Thermally processed milk showed high contamination levels, and among dairy products, cheeses were the most contaminated. This review highlights AFM1 as a persistent hazard in the dairy sector, underscoring the need for effective interventions throughout the milk production stages.

12 May 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
IAIOANNA AVAKIAN
IOANNA AVAKIAN
LALemonia Anagnostopoulos
Lemonia Anagnostopoulos
George RachiotisGeorge Rachiotis
George Rachiotis
KFKONSTANTINOS GEORGE FOTIADIS
KONSTANTINOS GEORGE FOTIADIS
AMAnargyros Mariolis
Anargyros Mariolis
Varvara MouchtouriVarvara Mouchtouri
Varvara Mouchtouri
Background: Τhe study aims to identify factors associated with COVID-19 vaccine acceptance and to investigate knowledge and perceptions of Primary Health Care Centers (PHCC) personnel, who acted as pioneers in the national COVID-19 vaccination strategy. Methods and Materials: A nationwide cross-sectional survey was conducted by distributing an online anonymous questionnaire comprising 25 questions during the first semester of 2021. Results: Approximately 85.3% of the 1136 respondents (response rate 28.4%) were vaccinated or intended to be. The acceptance of seasonal flu vaccine (aOR: 3.29, 95%CI: 2.08–5.20), correct COVID-19 vaccine knowledge (aOR: 8.37, 95%CI: 4.81–14.59) and lack of concern regarding vaccine novelty (aOR: 6.18, 95%CI: 3.91–9.77) were positively correlated with vaccine acceptance. Vaccinated respondents were more likely to be physicians (aOR: 2.29, 95%CI: 1.03–5.09) or administrative staff (aOR: 2.65, 95%CI: 1.18–5.97) compared to nursing stuff. Reasons for vaccine hesitancy included inadequate information (37.8%) and vaccine safety (31.9%). Vaccine acceptance was strongly correlated (Spearman’s correlation coefficient r = 0.991, p < 0.001) between PHCC personnel and the general population of each health district. Conclusions: COVID-19 vaccine acceptance among PHCC personnel in Greece was comparably high, but specific groups (nurses) were hesitant. As the survey’s target population could serve as a role model for the community, efforts should be made to improve COVID-19 vaccine acceptance.